Nephrotic syndrome classification: Difference between revisions
Jump to navigation
Jump to search
| Line 23: | Line 23: | ||
|- | |- | ||
! rowspan="6" align="center" style="background:#DCDCDC;" + |Podocytopathies | ! rowspan="6" align="center" style="background:#DCDCDC;" + |Podocytopathies | ||
| rowspan="2" |Primary | | rowspan="2" align="left" style="background:#F5F5F5;" + |Primary | ||
|[[Minimal change disease]] | | align="left" style="background:#F5F5F5;" + |[[Minimal change disease]] | ||
|- | |- | ||
|[[Focal segmental glomerulosclerosis]] ([[Focal segmental glomerulosclerosis|FSGS]]) | | align="left" style="background:#F5F5F5;" + |[[Focal segmental glomerulosclerosis]] ([[Focal segmental glomerulosclerosis|FSGS]]) | ||
|- | |- | ||
| rowspan="4" |Secondary | | rowspan="4" align="left" style="background:#F5F5F5;" + |Secondary | ||
|Infection such as: | | align="left" style="background:#F5F5F5;" + |Infection such as: | ||
* [[Human Immunodeficiency Virus (HIV)|HIV]] | * [[Human Immunodeficiency Virus (HIV)|HIV]] | ||
|- | |- | ||
|Drugs/toxins such as: | | align="left" style="background:#F5F5F5;" + |Drugs/toxins such as: | ||
* [[Non-steroidal anti-inflammatory drug|NSAIDs]] | * [[Non-steroidal anti-inflammatory drug|NSAIDs]] | ||
* Interferon | * Interferon | ||
| Line 40: | Line 40: | ||
* Envenomation | * Envenomation | ||
|- | |- | ||
|Malignancies such as: | | align="left" style="background:#F5F5F5;" + |Malignancies such as: | ||
* [[Hodgkin's lymphoma|Hodgkin lymphoma]] | * [[Hodgkin's lymphoma|Hodgkin lymphoma]] | ||
* [[Thymoma]] | * [[Thymoma]] | ||
|- | |- | ||
|Genetic disorders such as: | | align="left" style="background:#F5F5F5;" + |Genetic disorders such as: | ||
* [[Nephrin]] mutations | * [[Nephrin]] mutations | ||
* [[Podocin]] gene mutations | * [[Podocin]] gene mutations | ||
|- | |- | ||
! rowspan="2" align="center" style="background:#DCDCDC;" + |Membranous glomerulonephritis | ! rowspan="2" align="center" style="background:#DCDCDC;" + |Membranous glomerulonephritis | ||
|Primary | | align="left" style="background:#F5F5F5;" + |Primary | ||
|[[Membranous nephritis|Membranous nephropathy]] | | align="left" style="background:#F5F5F5;" + |[[Membranous nephritis|Membranous nephropathy]] | ||
|- | |- | ||
|Secondary | | align="left" style="background:#F5F5F5;" + |Secondary | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* [[Drugs]] | * [[Drugs]] | ||
* [[Toxin|Toxins]] | * [[Toxin|Toxins]] | ||
| Line 59: | Line 59: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Membranoproliferative glomerulonephritis | ! align="center" style="background:#DCDCDC;" + |Membranoproliferative glomerulonephritis | ||
|Secondary | | align="left" style="background:#F5F5F5;" + |Secondary | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Autoimmune disorders such as: | * Autoimmune disorders such as: | ||
** [[SLE]] | ** [[SLE]] | ||
| Line 72: | Line 72: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Hereditary Nephropathy | ! align="center" style="background:#DCDCDC;" + |Hereditary Nephropathy | ||
| colspan="2" | | | colspan="2" align="left" style="background:#F5F5F5;" + | | ||
* [[Alport syndrome]] | * [[Alport syndrome]] | ||
* [[IgA nephropathy]] | * [[IgA nephropathy]] | ||
| Line 78: | Line 78: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Glomerular deposition diseases | ! align="center" style="background:#DCDCDC;" + |Glomerular deposition diseases | ||
| colspan="2" | | | colspan="2" align="left" style="background:#F5F5F5;" + | | ||
* [[Diabetes mellitus]] | * [[Diabetes mellitus]] | ||
* [[Amyloidosis]] | * [[Amyloidosis]] | ||
| Line 85: | Line 85: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Other lesions | ! align="center" style="background:#DCDCDC;" + |Other lesions | ||
| colspan="2" | | | colspan="2" align="left" style="background:#F5F5F5;" + | | ||
* [[Fabry's disease|Fabry disease]] | * [[Fabry's disease|Fabry disease]] | ||
* [[Nail-patella syndrome]] | * [[Nail-patella syndrome]] | ||
Revision as of 00:55, 29 July 2018
|
Nephrotic Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nephrotic syndrome classification On the Web |
|
American Roentgen Ray Society Images of Nephrotic syndrome classification |
|
Risk calculators and risk factors for Nephrotic syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3] Yazan Daaboul,
Overview
Nephrotic syndrome can be classified into primary or secondary depending on the underlying etiology. Primary (idiopathic) nephrotic syndrome is defined as nephrotic syndrome due to a primary glomerular disease. Secondary nephrotic syndrome is defined as nephrotic syndrome due to a primary etiology other than glomerular disorders, such as infections, malignancies, systemic conditions, and medications.
Classification
- Nephrotic syndrome can be classified into primary or secondary depending on the underlying etiology.[1]
| Nephrotic syndrome | |||||||||||||||||||
| Primary | Secondary | ||||||||||||||||||
| Different types of nephrotic syndromes | Disease name | |
|---|---|---|
| Podocytopathies | Primary | Minimal change disease |
| Focal segmental glomerulosclerosis (FSGS) | ||
| Secondary | Infection such as: | |
Drugs/toxins such as:
| ||
| Malignancies such as: | ||
| Genetic disorders such as: | ||
| Membranous glomerulonephritis | Primary | Membranous nephropathy |
| Secondary | ||
| Membranoproliferative glomerulonephritis | Secondary |
|
| Hereditary Nephropathy |
| |
| Glomerular deposition diseases |
| |
| Other lesions | ||
References
- ↑ Kodner C (2009). "Nephrotic syndrome in adults: diagnosis and management". Am Fam Physician. 80 (10): 1129–34. PMID 19904897.
- ↑ Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA, Germain MJ (May 2000). "Changing incidence of glomerular diseases in adults". Am. J. Kidney Dis. 35 (5): 878–83. PMID 10793022.
- ↑ Heaf J (September 2004). "The Danish Renal Biopsy Register". Kidney Int. 66 (3): 895–7. doi:10.1111/j.1523-1755.2004.00832.x. PMID 15327377.
- ↑ Ha TS (March 2017). "Genetics of hereditary nephrotic syndrome: a clinical review". Korean J Pediatr. 60 (3): 55–63. doi:10.3345/kjp.2017.60.3.55. PMC 5383633. PMID 28392820.